Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Biomarkers of fibroproliferative healing in fibrosing idiopathic interstitial pneumonias

M. Vasakova, M. Sterclova, E. Stranska, P. Mandakova, J. Skibova, R. Matej,

. 2012 ; 6 () : 160-164.

Jazyk angličtina Země Nizozemsko

Perzistentní odkaz   https://www.medvik.cz/link/bmc13016264

Grantová podpora
NT13433 MZ0 CEP - Centrální evidence projektů

AIMS: The main feature of fibrosing idiopathic interstitial pneumonias (fIIPs) is the fibroproliferative potential of underlying pathogenetic process. We hypothesize that the concentration of potential markers of fibroproliferative healing, PAR-2, TGF-β1, TNF-α and IL-4Rα in bronchoalveolar lavage fluid (BALF) differ in patients with fIIPs compared to controls (C). PATIENTS AND METHODS: 10 patients with fIIPs and 9 controls (C) were included to the study. Concentrations of CD124 (IL4Rα), PAR-2, TGF-β1 and TNF-α in BALF were determined using the ELISA method. RESULTS: We observed higher concentrations of IL4Rα (fIIPS 1499.4 pg/ml vs C 255.5 pg/ml; p < 0.05), PAR-2 (fIIPS 1807.9 pg/ml vs C 421.0 pg/ml; p < 0.05) and TGF-β1(fIIPS 283.0 pg/ml vs C 197.1 pg/ml; p < 0.01) in BALF in fIIPs versus C. The values of TNF-a in BALF did not differ significantly in fIIPs compared to controls. The ratios also showed differences in fIIPS and C: IL4Rα/TGF-β1 (fIIPS 6.19 vs C 0.68; p = 0.0143); TNF-α/IL4Rα (fIIPS 0.84 vs C 7.93; p = 0.043); TGF-β1/TNF-α (fIIPS 0.21 vs C 0.16; p = 0.0179) and protein/PAR-2 (fIIPS 0.06 vs C 0.28; p = 0.0033). CONCLUSIONS: We found that PAR-2, TGF-β1 and IL-4Rα are significantly up-regulated in the BALF of fIIPs compared to controls, therefore we suppose they could become biomarkers of fibroproliferative healing.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13016264
003      
CZ-PrNML
005      
20170524123450.0
007      
ta
008      
130424s2012 ne f 000 0|eng||
009      
AR
024    7_
$a 10.2174/1874306401206010160 $2 doi
035    __
$a (PubMed)23346263
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Koziar Vašáková, Martina, $u Department of Respiratory Medicine, Thomayer Hospital, Videnska 800, 14059 Prague 4, Czech Republic. $d 1964- $7 xx0104496
245    10
$a Biomarkers of fibroproliferative healing in fibrosing idiopathic interstitial pneumonias / $c M. Vasakova, M. Sterclova, E. Stranska, P. Mandakova, J. Skibova, R. Matej,
520    9_
$a AIMS: The main feature of fibrosing idiopathic interstitial pneumonias (fIIPs) is the fibroproliferative potential of underlying pathogenetic process. We hypothesize that the concentration of potential markers of fibroproliferative healing, PAR-2, TGF-β1, TNF-α and IL-4Rα in bronchoalveolar lavage fluid (BALF) differ in patients with fIIPs compared to controls (C). PATIENTS AND METHODS: 10 patients with fIIPs and 9 controls (C) were included to the study. Concentrations of CD124 (IL4Rα), PAR-2, TGF-β1 and TNF-α in BALF were determined using the ELISA method. RESULTS: We observed higher concentrations of IL4Rα (fIIPS 1499.4 pg/ml vs C 255.5 pg/ml; p < 0.05), PAR-2 (fIIPS 1807.9 pg/ml vs C 421.0 pg/ml; p < 0.05) and TGF-β1(fIIPS 283.0 pg/ml vs C 197.1 pg/ml; p < 0.01) in BALF in fIIPs versus C. The values of TNF-a in BALF did not differ significantly in fIIPs compared to controls. The ratios also showed differences in fIIPS and C: IL4Rα/TGF-β1 (fIIPS 6.19 vs C 0.68; p = 0.0143); TNF-α/IL4Rα (fIIPS 0.84 vs C 7.93; p = 0.043); TGF-β1/TNF-α (fIIPS 0.21 vs C 0.16; p = 0.0179) and protein/PAR-2 (fIIPS 0.06 vs C 0.28; p = 0.0033). CONCLUSIONS: We found that PAR-2, TGF-β1 and IL-4Rα are significantly up-regulated in the BALF of fIIPs compared to controls, therefore we suppose they could become biomarkers of fibroproliferative healing.
650    12
$a idiopatické intersticiální pneumonie $7 D054988
650    12
$a receptor PAR-2 $7 D044464
650    12
$a receptory interleukinu-4 $7 D019948
650    12
$a transformující růstový faktor beta $7 D016212
650    12
$a bronchoalveolární lavážní tekutina $7 D001992
650    12
$a biologické markery $7 D015415
650    12
$a idiopatická plicní fibróza $7 D054990
650    _2
$a lidé $7 D006801
653    00
$a IL4R.; Idiopathic interstitial pneumonias; PAR-2; TGF-beta; biomarkers; bronchoalveolar lavage fluid; fibroproliferative healing
700    1_
$a Šterclová, Martina, $d 1979- $7 xx0108032
700    1_
$a Stránská, Eliška $7 xx0143239
700    1_
$a Manďáková, Petra $7 xx0121856
700    1_
$a Skibová, Jelena $7 xx0061183
700    1_
$a Matěj, Radoslav, $d 1974- $7 xx0103860
773    0_
$w MED00165360 $t The open respiratory medicine journal $x 1874-3064 $g Roč. 6(2012), s. 160-164
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23346263 $y Pubmed
910    __
$a ABA008 $b sig $y 4 $z 0
990    __
$a 20130424 $b ABA008
991    __
$a 20170524123847 $b ABA008
999    __
$a ok $b bmc $g 979465 $s 814585
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 6 $d 160-164 $i 1874-3064 $m The open respiratory medicine journal $n Open Respir Med J $x MED00165360
GRA    __
$a NT13433 $p MZ0
LZP    __
$a Pubmed-20130424

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...